Loni Anderson's cause of death was metastatic uterine leiomyosarcoma, a rare and aggressive form of cancer. She passed away ...

In a preclinical study, researchers found tamoxifen encourages uterine cell growth; the findings could change how some breast ...

Studies show that people receiving tamoxifen, a highly effective and commonly used therapy to treat breast cancer, face a 2- ...

In a preclinical study, researchers found tamoxifen encourages uterine cell growth; the findings could change how some breast ...

The intervention being tested is BNT323/DB-1303, an investigational drug administered via intravenous infusion. It is compared against standard chemotherapy options, doxorubicin or paclitaxel, chosen ...

An international research team has identified a previously unknown mechanism by which the breast cancer drug tamoxifen can ...

Loni Anderson’s cause of death has been confirmed as a rare and aggressive form of uterine cancer that occurs in just 6 out ...

The interventions being tested include Trastuzumab deruxtecan (T-DXd), an experimental therapy, combined with either Rilvegostomig or Pembrolizumab, both administered via intravenous infusion. These ...

The National Cancer Institute of the National Institutes of Health has awarded Dr. Anna Gottschlich, assistant professor of oncology in the Wayne State University School of Medicine and the Barbara ...

People with obesity who take weight loss and diabetes drugs like Ozempic and Mounjaro could face a lower risk of cancer ...

For many women, cancer feels like a distant concern, something to think about only later in life. But the numbers tell a ...

Glucagon-like peptide-1 (GLP-1) receptor agonists show promise in reducing cancer risk among patients with obesity, particularly for endometrial, ovarian, and meningioma cancers.